Redefining CKD Care: Manage Hyperkalemia, Enable GDMT

Chronic kidney disease (CKD) management is no longer focused only on slowing the decline in kidney function. Modern CKD care also aims to reduce cardiovascular risk, control complications, and help patients remain on evidence-based therapies that can protect both the kidneys and the heart.

One of the important challenges in this process is hyperkalemia, or an abnormally high potassium level in the blood.

Hyperkalemia can limit the use of some guideline-directed medical therapies, especially medicines that act on the renin-angiotensin-aldosterone system. Effective potassium management may help eligible patients continue therapies that provide important kidney and cardiovascular benefits.

What Is Hyperkalemia?

Potassium is an essential mineral that helps regulate normal muscle function, nerve activity, and heart rhythm.

Healthy kidneys remove excess potassium from the body. When kidney function declines, potassium may accumulate in the blood, particularly in people with advanced CKD or those taking certain medicines.

Hyperkalemia is especially important because significantly elevated potassium levels can interfere with the electrical activity of the heart.

Why Is Hyperkalemia Common in CKD?

People with CKD have a reduced ability to excrete potassium through the kidneys.

The risk may be higher in patients with:

• Advanced chronic kidney disease
• Diabetes
• Heart failure
• Metabolic acidosis
• Certain medications that increase potassium levels
• High dietary potassium intake in susceptible individuals
• Episodes of acute kidney injury

Because CKD and cardiovascular disease frequently occur together, many patients may also require medicines that can affect potassium levels.

The Connection Between CKD, Hyperkalemia and GDMT

GDMT stands for Guideline-Directed Medical Therapy.

Depending on a patient's condition, GDMT may include medicines such as:

ACE inhibitors or ARBs: Commonly used for blood pressure control and kidney protection, particularly in people with albuminuria.

Mineralocorticoid receptor antagonists: Used in selected patients with heart failure and certain kidney-related indications.

Other kidney- and heart-protective therapies: These may be added according to the patient's individual clinical condition.

These medications can provide significant benefits, but some of them may increase serum potassium.

When potassium levels rise, doctors may need to reduce, temporarily hold, or reassess medications depending on the severity and clinical circumstances.

The goal is therefore not simply to stop beneficial therapy at the first sign of elevated potassium. Instead, the underlying cause should be assessed and hyperkalemia managed appropriately so that suitable patients can continue evidence-based treatment whenever it is safe to do so.

Why Maintaining GDMT Matters

For appropriately selected patients, guideline-directed therapies may help:

• Slow CKD progression
• Reduce albuminuria
• Improve blood pressure control
• Lower cardiovascular risk
• Reduce complications associated with heart failure
• Delay progression toward kidney failure in some patients

However, treatment decisions must always balance these benefits against potential risks such as hyperkalemia, low blood pressure, or changes in kidney function.

Regular monitoring is therefore essential.

How Is Hyperkalemia Managed?

The treatment of hyperkalemia depends on the potassium level, symptoms, ECG findings, kidney function, medications, and overall clinical condition.

1. Review Medications

The treating doctor may review medicines and supplements that can increase potassium.

Medication changes should never be made without medical advice, because abruptly stopping certain kidney- or heart-protective medicines may not be appropriate.

2. Assess Dietary Potassium

Some patients may benefit from individualized dietary advice.

However, potassium restriction should not be applied unnecessarily to every person with CKD. Dietary recommendations should consider the patient's potassium level, kidney function, medications, nutrition, and overall diet.

A renal dietitian can be helpful in selected cases.

3. Correct Other Contributing Factors

Doctors may assess for conditions that worsen hyperkalemia, such as:

• Dehydration
• Acute kidney injury
• Metabolic acidosis
• Uncontrolled diabetes
• Constipation in certain situations

Treating contributing factors may help improve potassium control.

4. Consider Diuretics When Appropriate

In selected patients who retain fluid and still produce urine, certain diuretics may help increase urinary potassium excretion.

This treatment must be individualized based on blood pressure, kidney function, and fluid status.

5. Use Potassium-Lowering Therapies When Needed

Potassium binders may be used in selected patients to help reduce potassium levels.

In some cases, chronic potassium management can make it easier for patients to remain on beneficial kidney- and heart-protective therapies.

The choice of treatment depends on the severity, urgency, and overall clinical situation.

Acute Hyperkalemia Is a Medical Emergency

Severe hyperkalemia can be dangerous and may require urgent hospital treatment.

Emergency treatment may include measures that:

• Stabilize the heart
• Temporarily shift potassium into cells
• Remove potassium from the body
• Correct the underlying cause

Dialysis may be required in certain severe cases, particularly when hyperkalemia cannot be controlled with other measures or when significant kidney failure is present.

Monitoring Is the Key to Safer CKD Treatment

CKD treatment should be dynamic rather than static.

Patients receiving medicines that can affect potassium or kidney function may need periodic monitoring of:

• Serum potassium
• Serum creatinine
• eGFR
• Blood pressure
• Fluid status
• Urinary albumin, when clinically relevant

Monitoring allows treatment to be adjusted early and safely.

Manage Hyperkalemia, Don't Ignore It

Hyperkalemia should not be viewed as an isolated laboratory abnormality.

In many CKD patients, it can influence the ability to continue important kidney- and heart-protective therapies.

A more comprehensive approach involves:

Detecting hyperkalemia early
Identifying the cause
Correcting reversible factors
Managing potassium appropriately
Continuing beneficial GDMT when clinically safe

This approach can help physicians provide more complete cardiorenal care.

Redefining CKD Care

Modern CKD management requires attention to both kidney function and cardiovascular health.

Rather than treating each problem separately, nephrology care increasingly focuses on the interaction between kidney disease, heart disease, blood pressure, diabetes, electrolyte balance, and medications.

For many patients, effectively managing hyperkalemia can be an important part of maintaining therapies that support long-term kidney and cardiovascular health.

Conclusion

Hyperkalemia is a common and clinically important complication of chronic kidney disease. It can also create challenges when using guideline-directed therapies that protect the kidneys and cardiovascular system.

The goal should be a personalized approach: identify hyperkalemia early, manage it appropriately, monitor kidney function and potassium carefully, and enable evidence-based treatment whenever it can be continued safely.

Patients with CKD should not change potassium intake or stop kidney or heart medicines without discussing the situation with their nephrologist.

Dr. Gagan Deep Chhabra
Director & Unit Head – Nephrology & Kidney Transplant
Fortis Hospital, Gurugram

📍 Gurugram | Vasant Kunj | Chittaranjan Park